MABTHERA

This brand name is authorized in Austria, Australia, Brazil, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug MABTHERA contains one active pharmaceutical ingredient (API):

1 Rituximab UNII 4F4X42SYQ6 - RITUXIMAB

Rituximab binds specifically to the transmembrane antigen, CD20, a non-glycosylated phosphoprotein, located on pre-B and mature B lymphocytes. The antigen is expressed on >95% of all B cell non-Hodgkin’s lymphomas. Read about Rituximab

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01FA01	Rituximab	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FA CD20 (Clusters of Differentiation 20) inhibitors
Discover more medicines within L01FA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10703H, 10708N, 10709P, 10710Q, 10719E, 10720F, 10741H, 10742J, 11942M, 11988Y
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 529203301153217, 529203302151218, 529216020026403
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 24.240-1-05-11, 36-MBE-1215
Country: EE	Ravimiamet	Identifier(s): 1041398, 1041400, 1645534, 1720437
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 198067003, 98067001, 98067002
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 494237, 494286, 545104
Country: FR	Base de données publique des médicaments	Identifier(s): 62002638, 65314657, 65348481
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 247803, 76960, 76972
Country: HK	Department of Health Drug Office	Identifier(s): 46231, 46232, 59248, 59249, 64699, 65562
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 4944, 4945, 7851
Country: IT	Agenzia del Farmaco	Identifier(s): 033315019, 033315021, 033315033
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1011145, 1011146, 1074075, 1080831
Country: NL	Z-Index G-Standaard	Identifier(s): 14219557, 14219565
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 117005, 51004, 51012
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15906, 17802, 8039
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100086903, 100325213, 100383848, 100383854
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64385001, W64386001, W64387001, W66651001
Country: SG	Health Sciences Authority	Identifier(s): 09946P, 13718P, 15023P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 6993141H, 6993142H, 6993143H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699505763361, 8699505763378, 8699505772813
Country: ZA	Health Products Regulatory Authority	Identifier(s): 32/26/0578, 32/26/0579, 49/30.1/0466